TMPRSS2, a Serine Protease Expressed in the Prostate on the Apical Surface of Luminal Epithelial Cells and Released into Semen in Prostasomes, Is Misregulated in Prostate Cancer Cells
- 30 June 2010
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 176 (6), 2986-2996
- https://doi.org/10.2353/ajpath.2010.090665
Abstract
No abstract availableKeywords
Funding Information
- National Science Council (NSC 97-2320-B-00-052-MY3)
- National Cancer Institute (RO1 CA 096851, RO1 CA 104944)
This publication has 42 references indexed in Scilit:
- Type II Transmembrane Serine ProteasesJournal of Biological Chemistry, 2009
- Quantitative expression of TMPRSS2 transcript in prostate tumor cells reflects TMPRSS2–ERG fusion statusProstate Cancer and Prostatic Diseases, 2009
- Identification of PDE4D as a Proliferation Promoting Factor in Prostate Cancer Using a Sleeping Beauty Transposon-Based Somatic Mutagenesis ScreenCancer Research, 2009
- Purification from human milk of matriptase complexes with secreted serpins: mechanism for inhibition of matriptase other than HAI-1American Journal of Physiology-Cell Physiology, 2008
- TMPRSS2:ERG Fusion by Translocation or Interstitial Deletion Is Highly Relevant in Androgen-Dependent Prostate Cancer, But Is Bypassed in Late-Stage Androgen Receptor–Negative Prostate CancerCancer Research, 2006
- Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate CancerScience, 2005
- The membrane-anchored serine protease, TMPRSS2, activates PAR-2 in prostate cancer cellsBiochemical Journal, 2005
- Characteristics of human prostasomes isolated from three different sourcesThe Prostate, 2003
- Type II transmembrane serine proteasesThrombosis and Haemostasis, 2003
- Monoclonal antibodies against human prostasomesThe Prostate, 1998